| Filed On | Filing |
|---|---|
| 27 Oct 2026 | SCHEDULE 13G/A |
| 22 Oct 2026 |
Form 4: Venker Eric, President & Immunovant CEO
Sold 200,000 shares ($7.02M) |
| 21 Oct 2026 |
8-K: Regulation FD Disclosure
Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU) |
| 20 Oct 2026 |
Form 4: Sukhatme Mayukh, Director
Gave up 19,976 shares to cover exercise price or tax ($670K) |
| 20 Oct 2026 |
Form 4: Gline Matthew, Director
Gave up 34,638 shares to cover exercise price or tax ($1.16M) |
| 20 Oct 2026 | 144 |
| 05 Oct 2026 |
Form 4: Epperly Melissa B,, Director
Received 17,750 shares by exercise or conversion ($79.2K) · Sold 17,750 shares ($641K) |
| 05 Oct 2026 | SCHEDULE 13D/A |
| 05 Oct 2026 |
Form 4: Roivant Sciences Ltd., Director · Arbutus Biopharma Corp
Returned 8,967,383 shares to the issuer ($44.8M) |
| 02 Oct 2026 |
Form 4: Sukhatme Mayukh, Director
Gave up 46,879 shares to cover exercise price or tax ($1.71M) |
| 02 Oct 2026 |
Form 4: Venker Eric, President & Immunovant CEO
Received 200,000 shares by exercise or conversion ($770K) · Sold 200,000 shares ($7.32M) |
| 02 Oct 2026 |
Form 4: Gline Matthew, Director
Gave up 76,171 shares to cover exercise price or tax ($2.79M) |
| 02 Oct 2026 |
Form 4: Torti Frank, President and Vant Chair
Acquired 40,309 shares (Exercise Price / Tax Payment) ($1.47M) |
| 30 Sep 2026 | 144 |
| 22 Sep 2026 |
Form 4: Pulik Richard, CFO
Gave up 2,129 shares to cover exercise price or tax ($84.7K) |
| 22 Sep 2026 |
Form 4: Humes Jennifer, Chief Accounting Officer
Gave up 3,880 shares to cover exercise price or tax ($154K) |
| 18 Sep 2026 |
Form 4: Gold Daniel Allen, Director
Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy) |
| 18 Sep 2026 |
Form 4: Oren Ilan, Director
Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy) |
| 18 Sep 2026 |
Form 4: Manchester Keith S, Director
Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy) |
| 18 Sep 2026 |
Form 4: Epperly Melissa B,, Director
Received 5,054 shares as a grant or award · Granted 10,531 Stock Option (Right to Buy) |
Loading...